logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11666556 B1

PDFFull Text
Date of Patent:
Jun. 06, 2023

Filed:

May. 28, 2019

Pharmaceutical combination, composition and compound preparation containing glucokinase activator and k-atp channel blocker, preparation method therefor and use thereof

Applicant:

Hua Medicine (Shanghai) Ltd., Shanghai, CN;

Inventors:

Li Chen, Shanghai, CN;

Yongguo Li, Shanghai, CN;

Gaosen Wang, Shanghai, CN;

Huisheng Gao, Shanghai, CN;

Assignee:

HUA MEDICINE (SHANGHAI) LIMITED, Shanghai, CN;

Attorney:

Jones Day

Primary Examiner:

Savitha M Rao

Int. Cl.
CPC ...
A61K 31/4155 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/155 (2006.01); A61P 3/10 (2006.01); A61K 9/16 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/4985 (2006.01); A61K 31/522 (2006.01); A61K 31/4035 (2006.01); A61K 31/4439 (2006.01); A61K 31/7034 (2006.01); C07D 403/12 (2006.01); A61K 47/38 (2006.01); C07D 231/38 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4155 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1635 (2013.01); A61K 9/1694 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2086 (2013.01); A61K 9/2095 (2013.01); A61K 9/284 (2013.01); A61K 9/2813 (2013.01); A61K 9/2866 (2013.01); A61K 31/155 (2013.01); A61K 31/40 (2013.01); A61K 31/403 (2013.01); A61K 31/4035 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/522 (2013.01); A61K 31/7034 (2013.01); A61K 45/06 (2013.01); A61K 47/38 (2013.01); A61P 3/10 (2018.01); C07D 231/38 (2013.01); C07D 403/12 (2013.01);
Abstract

The present invention relates to a pharmaceutical combination, the pharmaceutical combination comprising a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic label thereof, a crystal form thereof, a hydrate, a solvate, a diastereomer or enantiomer, and a K-ATP channel blocker. The present invention further relates to a pharmaceutical composition, a fixed dose compound preparation, and a method for preparing the pharmaceutical composition and the fixed dose compound preparation as well as a use thereof.

Find Patent Forward Citations

Chen, Li. (2023). Pharmaceutical combination, composition and compound preparation containing glucokinase activator and k-atp channel blocker, preparation method therefor and use thereof (U.S. Patent No. 11666556). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11666556

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…